Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rank in Stocks #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Share Price
$4.51
Market Cap
$540.82M
Change (1 day)
-2.42%
Change (1 year)
-43.50%
Country
CN
Trade Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Category

Stock split history for Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Nanjing Hicin Pharmaceutical Co., Ltd. stock (symbol: 300584) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 31, 2026.
One 300584 share bought prior to Aug 31, 2026 would equal to 0 300584 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors